ArticleJournal of Cancer2018

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.

Fangzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.